|
⚲
|
| Keyboard |
| BVF Partners L P/IL
✚
|
|
|---|---|
| CIK # | 0001055947 |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Kymera Therapeutics Inc | 0.5 | ||
| Helix Acquisition Corp | 0.3 | ||
| Revolution Medicines Inc | 0.3 | ||
| Nektar Therapeutics | 0.2 | ||
| Structure Therapeutics Inc | 0.2 | ||
| Mirum Pharmaceuticals Inc | 0.1 | ||
| GH Research PLC | 0.1 | ||
| Marika Inc | 0.1 | ||
| Zymeworks Inc | 0.1 | ||
| Xencor Inc | 0.1 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-NT | [0001055947] | |
| 3 | [0001055947] | |
| 4 | [0001055947] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Repare Therapeutics Inc RPTX
Common Shares, no par value
|
2026-01-28 | Tender | 548,938 | ||
|
Repare Therapeutics Inc RPTX
Common Shares, no par value
|
2026-01-28 | Tender | 5,309,432 | ||
|
Repare Therapeutics Inc RPTX
Common Shares, no par value
|
2026-01-28 | Tender | 4,308,573 | ||
|
ESSA Pharma Inc EPIX
Common Stock
|
2025-10-09 | Tender | 4,726,743 | ||
|
ESSA Pharma Inc EPIX
Common Stock
|
2025-10-09 | Tender | 6,194,145 | ||
|
ESSA Pharma Inc EPIX
Common Stock
|
2025-10-09 | Tender | 560,797 | ||
|
ESSA Pharma Inc EPIX
Common Stock
|
2025-08-05 | Sell | 66 | $1.88 | 124 |
|
ESSA Pharma Inc EPIX
Common Stock
|
2025-08-05 | Option exercise | 1,481,634 | $0.00 | |
|
ESSA Pharma Inc EPIX
Common Stock
|
2025-08-05 | Option exercise | 203,336 | $0.00 | |
|
ESSA Pharma Inc EPIX
Common Stock
|
2025-08-05 | Option exercise | 1,235,030 | $0.00 | |
|
ESSA Pharma Inc EPIX
Pre-funded Warrants · derivative
|
2025-08-05 | Option exercise | 1,481,634 | $0.00 | |
|
ESSA Pharma Inc EPIX
Pre-funded Warrants · derivative
|
2025-08-05 | Option exercise | 1,235,030 | $0.00 | |
|
ESSA Pharma Inc EPIX
Common Stock
|
2025-08-05 | Sell | 11 | $1.88 | 21 |
|
ESSA Pharma Inc EPIX
Pre-funded Warrants · derivative
|
2025-08-05 | Option exercise | 203,336 | $0.00 | |
|
ESSA Pharma Inc EPIX
Common Stock
|
2025-08-05 | Sell | 79 | $1.88 | 149 |
|
Kymera Therapeutics Inc KYMR
Common Stock, $0.0001 par value
|
2025-06-30 | Buy | 142,604 | $44.00 | 6,274,576 |
|
Kymera Therapeutics Inc KYMR
Common Stock, $0.0001 par value
|
2025-06-30 | Buy | 58,780 | $44.00 | 2,586,320 |
|
Kymera Therapeutics Inc KYMR
Common Stock, $0.0001 par value
|
2025-06-30 | Buy | 115,783 | $44.00 | 5,094,452 |
|
Kymera Therapeutics Inc KYMR
Stock Option (Right to Buy) · derivative
|
2025-06-25 | Grant | 16,000 | $0.00 | |
|
Crescent Biopharma Inc CBIO
Pre-Funded Warrants to Purchase Common Stock · derivative
|
2025-06-13 | Other | 257,515 | ||
| showing 20 of 200 most recent transactions | |||||